Clinical Trials Resource Center

Therapeutic Areas: Dermatology

Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Tucson Arizona 85724

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

Arkansas

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

California

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Alopecia Areata or Scarring Alopecia

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Hair Disease

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Androgenic Alopecia

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Santa Ana California 92701

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Santa Monica California 90404

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Santa Rosa California 95405

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Connecticut

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Florida

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33624

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Georgia

Newnan Georgia 30263

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Indiana

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Kansas

Wichita Kansas 67207

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Massachusetts

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Michigan

Clinton Michigan 48038

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Minnesota

Fridley Minnesota 55432

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Montana

Stevensville Montana 59870

A clinical trial seeking patients for a research study for the treatment of Alopecia Areata or Scarring Alopecia

New York

Mount Sinai Medical Center
New York New York 10029

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

Sadick Research Group
New York New York 10075

Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement with Standardized Botanicals for Treatment of Hair Loss and Thinning in Females

New York New York 10029

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

North Carolina

Winston-Salem North Carolina 27157

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Ohio

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Oklahoma

Tulsa Oklahoma 74136-7028

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Oregon

Portland Oregon 97210

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Portland Oregon 97223

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Portland Oregon 97210

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Pennsylvania

Hershey Pennsylvania 17033

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

South Carolina

Greer South Carolina 29650

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

South Dakota

Rapid City South Dakota 57702

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Texas

Research Across America, Plano
Plano Texas 75093

Hair Loss Study For Men & Women

Austin Texas 78759

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Katy Texas 77494

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Virginia

Lynchburg Virginia 24501

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Norfolk Virginia 23502

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Belgium

Brussels

A Phase 3 clinical study for patients with Alopecia, Androgenetic

Brussels

A Phase 3 clinical study for patients with Alopecia, Androgenetic